You’ve probably heard of the term “CBD” before. From bud and vape oils to bath bombs and body lotions, everything is getting infused with the stuff. Cannabidiol—its real name—is said to relieve pain, anxiety, and a range of disorders. Just last month, the FDA approved Epidiolex, a CBD-based drug, to treat two major forms of epilepsy.
Sativa Investments (LON:SATI) seeks to invest in companies which are well-placed to take advantage of the dynamic regulatory environment surrounding medical Cannabis. Our investment strategy focuses on production, pharmacology, testing and compliance, R&D commercialisation, and sales and marketing. The Directors are already engaging with possible target investments in their key areas of interest.